1.3 C
New York
Tuesday, January 31, 2023

Value Investing Philosophy And Aspira Women’s Health Inc. (NASDAQ: AWH)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Aspira Women’s Health Inc. (AWH) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0213, or 4.45%, to $0.50. The Aspira Women’s Health Inc. has recorded 1 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Aspira Women’s Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

AWH belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $0.48 and fluctuated between $0.5200 as its day high and $0.4500 as its day low. The current market capitalization of Aspira Women’s Health Inc. is $52.18M. A total of 0.56 million shares were traded on the day, compared to an average of 216.55K shares.

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, AWH has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 0 SELLs from insiders. Insiders purchased 940,334 shares during that period but sold 0.

In the most recent transaction, Palmieri Valerie Barber bought 43,994 shares of AWH for 0.57 per share on May 16. After the transaction, the Executive Chair now owns 267,088 company shares. In a previous transaction on May 16, Sandford Nicole bought 98,000 shares at 0.76 per share. AWH shares that President and CEO owns now total 136,160.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AWH in the last 3 months, the mean price target is $3.00 with high estimates of $3.00 and low estimates of $3.00. In terms of 52-week highs and lows, AWH has a high of $1.50 and a low of $0.28.

As of this writing, AWH has an earnings estimate of -$0.06 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.07.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 2 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AWH is Buy with a score of 4.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles